Is China National Accord Medicines (SZSE:000028) A Risky Investment?
Jun 12
Chinese (SSE) Healthcare Services Industry Analysis
UpdatedJun 14, 2024
DataAggregated Company Financials
Companies40
- 7D-1.2%
- 3M-13.3%
- 1Y-33.7%
- YTD-19.4%
Over the last 7 days, the Healthcare Services industry has dropped 1.2%, driven by a pullback from China National Accord Medicines of 9.0%. Overall the industry is down 34% in 12 months. As for the next few years, earnings are expected to grow by 22% per annum.
Industry Valuation and Performance
Has the Chinese Healthcare Services Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Fri, 14 Jun 2024 | CN¥539.3b | CN¥988.5b | CN¥22.5b | 30.2x | 24x | 0.5x |
| Sun, 12 May 2024 | CN¥598.5b | CN¥988.3b | CN¥22.4b | 34.3x | 26.7x | 0.6x |
| Tue, 09 Apr 2024 | CN¥577.6b | CN¥986.2b | CN¥19.4b | 28.8x | 29.7x | 0.6x |
| Thu, 07 Mar 2024 | CN¥617.4b | CN¥977.8b | CN¥20.1b | 29.8x | 30.7x | 0.6x |
| Sat, 03 Feb 2024 | CN¥554.6b | CN¥976.6b | CN¥19.8b | 27.7x | 28x | 0.6x |
| Mon, 01 Jan 2024 | CN¥678.0b | CN¥976.1b | CN¥19.9b | 33.3x | 34x | 0.7x |
| Wed, 29 Nov 2023 | CN¥725.9b | CN¥976.1b | CN¥19.9b | 32.3x | 36.4x | 0.7x |
| Fri, 27 Oct 2023 | CN¥692.3b | CN¥983.4b | CN¥21.5b | 27.1x | 32.3x | 0.7x |
| Sun, 24 Sep 2023 | CN¥724.3b | CN¥982.2b | CN¥21.2b | 29.5x | 34.2x | 0.7x |
| Tue, 22 Aug 2023 | CN¥729.1b | CN¥956.6b | CN¥23.2b | 23.9x | 31.4x | 0.8x |
| Thu, 20 Jul 2023 | CN¥771.2b | CN¥948.1b | CN¥23.0b | 25.3x | 33.5x | 0.8x |
| Sat, 17 Jun 2023 | CN¥802.2b | CN¥948.0b | CN¥23.0b | 26.7x | 35x | 0.8x |
| Mon, 15 May 2023 | CN¥828.6b | CN¥947.9b | CN¥22.9b | 26.2x | 36.1x | 0.9x |
| Wed, 12 Apr 2023 | CN¥856.1b | CN¥909.7b | CN¥26.9b | 31.2x | 31.9x | 0.9x |
| Fri, 10 Mar 2023 | CN¥834.1b | CN¥906.6b | CN¥26.4b | 30.6x | 31.5x | 0.9x |
| Sun, 05 Feb 2023 | CN¥854.2b | CN¥906.0b | CN¥26.4b | 29.2x | 32.4x | 0.9x |
| Tue, 03 Jan 2023 | CN¥803.3b | CN¥905.7b | CN¥26.4b | 28.3x | 30.5x | 0.9x |
| Thu, 01 Dec 2022 | CN¥761.3b | CN¥905.7b | CN¥26.4b | 29.7x | 28.9x | 0.8x |
| Sat, 29 Oct 2022 | CN¥652.1b | CN¥865.0b | CN¥25.0b | 23x | 26.1x | 0.8x |
| Mon, 26 Sep 2022 | CN¥625.0b | CN¥842.5b | CN¥23.8b | 20.1x | 26.2x | 0.7x |
| Wed, 24 Aug 2022 | CN¥680.4b | CN¥837.3b | CN¥22.9b | 30.7x | 29.8x | 0.8x |
| Fri, 22 Jul 2022 | CN¥773.2b | CN¥840.7b | CN¥24.0b | 31x | 32.2x | 0.9x |
| Sun, 19 Jun 2022 | CN¥716.2b | CN¥839.0b | CN¥23.9b | 24.8x | 29.9x | 0.9x |
| Tue, 17 May 2022 | CN¥672.5b | CN¥839.0b | CN¥23.9b | 26.2x | 28.1x | 0.8x |
| Thu, 14 Apr 2022 | CN¥667.9b | CN¥820.1b | CN¥28.2b | 26.9x | 23.7x | 0.8x |
| Sat, 12 Mar 2022 | CN¥657.5b | CN¥806.8b | CN¥26.8b | 26.5x | 24.5x | 0.8x |
| Mon, 07 Feb 2022 | CN¥634.7b | CN¥805.6b | CN¥26.7b | 23.8x | 23.8x | 0.8x |
| Wed, 05 Jan 2022 | CN¥787.0b | CN¥805.6b | CN¥26.7b | 29.3x | 29.5x | 1x |
| Fri, 03 Dec 2021 | CN¥718.9b | CN¥802.0b | CN¥26.5b | 23.2x | 27.1x | 0.9x |
| Sun, 31 Oct 2021 | CN¥768.7b | CN¥797.9b | CN¥26.9b | 23.4x | 28.6x | 1x |
| Tue, 28 Sep 2021 | CN¥818.8b | CN¥793.2b | CN¥27.2b | 23.3x | 30.1x | 1x |
| Thu, 26 Aug 2021 | CN¥763.8b | CN¥791.5b | CN¥27.0b | 24.2x | 28.3x | 1x |
| Fri, 02 Jul 2021 | CN¥1.1t | CN¥791.5b | CN¥27.0b | 29.4x | 39x | 1.3x |
Price to Earnings Ratio
39x
Current Industry PE
- Investors are pessimistic on the Chinese Healthcare industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading at a PE ratio of 24.0x which is lower than its 3-year average PE of 30.4x.
- The industry is trading close to its 3-year average PS ratio of 0.83x.
Past Earnings Growth
- The earnings for companies in the Healthcare industry have declined 5.9% per year over the last three years.
- Meanwhile revenues for these companies have grown 7.7% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.
Industry Trends
Which industries have driven the changes within the Chinese Healthcare industry?
| CN Market | -0.066% | |
| Healthcare | -0.038% | |
| Healthcare Services | -1.20% | |
| Healthcare Facilities | 1.20% | |
| Managed Healthcare | 0% | |
| Healthcare Services | -0.29% | |
| Healthcare Distributors | -2.79% | |
Industry PE
- Investors are most optimistic about the Healthcare Facilities industry even though it's trading below its 3-year average PE ratio of 251x.
- Analysts are expecting annual earnings growth of 25.6%, which is higher than its past year's earnings growth of 17.9% per year.
- Investors are most pessimistic about the Healthcare Distributors industry, which is trading close to its 3-year average of 18.1x.
Forecasted Growth
- Analysts are most optimistic on the Healthcare Services industry, expecting annual earnings growth of 32% over the next 5 years.
- This is better than its past earnings decline of 45% per year.
- In contrast, the Healthcare Distributors industry is expected to see its earnings grow by 17% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 301267 Huaxia Eye Hospital GroupLtd | CN¥24.48 | 1.5% +CN¥300.5m | -47.0% | PE30.4x | |
| 2044 Meinian Onehealth Healthcare Holdings | CN¥4.13 | 1.5% +CN¥233.4m | -40.6% | PE41.1x | |
| 300244 Dian Diagnostics GroupLtd | CN¥13.13 | 1.7% +CN¥136.3m | -50.6% | PE47.7x | |
| 301293 Sanbo Hospital Management Group | CN¥52.35 | 1.5% +CN¥120.4m | -48.0% | PE95.4x | |
| 301103 Liaoning He Eye Hospital Group | CN¥22.90 | 2.2% +CN¥76.7m | -45.7% | PE100.5x |
